Joe Rogan Peptides 2026: Retatrutide & BPC-157

Joe Rogan Peptides 2026: Retatrutide & BPC-157. What peptides does Joe Rogan take? See episode citations and research on BPC-157, TB-500, retatrutide, MOTS-c, and thymosin. Key Takeaways Joe Rogan has discussed peptides on multiple JRE episodes: Conversations with Andrew Huberman, Derek (More Plates More Dates), and others cover various peptide compounds BPC-157 and TB-500 are frequently mentioned: Rogan has discussed these compounds in the context of recovery and tissue research Thymosin Alpha-1 and Ipamorelin also cited: Mentioned specifically on his Flagrant podcast appearance All peptides discussed are research compounds: Not FDA-approved medications for human treatment Published preclinical research exists: This article cites the peer-reviewed studies on compounds Rogan has mentioned Joe Rogan's podcast is the most popular on Spotify, with millions of downloads per episode. His discussions on health optimization topics—including peptides—have introduced many listeners to compounds previously confined to research literature. This article documents what Joe Rogan has actually said about peptides, with episode citations and timestamps where available. More importantly, we examine the published research on each compound he's mentioned to provide scientific context — including nootropic-class compounds like Selank that frequently come up in optimization conversations. Framing note: This is not a recommendation to "do what Joe does." Rogan shares his personal experiences on his podcast. This article separates his statements from the published science and clarifies that these compounds remain research tools, not approved treatments. What Joe Rogan Has Said About Peptides Rogan has discussed peptides across multiple episodes and podcast appearances. Here's what he's actually said, with citations. JRE Episode #1580 — Andrew Schulz During this conversation, Rogan explained how he first learned about peptides: "My doctor actually told me about peptides a long time ago. They accentuate healing. There's a lot of articles about them. Athletes swear by them." This quote establishes that Rogan's introduction to peptides came through a medical professional, and he acknowledges their use in athletic contexts. Flagrant Podcast (June 2022, ~2:16:00) On Andrew Schulz's Flagrant podcast, Rogan was more specific about which peptides he's discussed: "BPC-157, Ipamorelin, Thymosin... they encourage your body to produce more of the hormones that it used to produce at a younger age." This statement names three specific compounds. Note that Rogan's description is a simplified explanation—the mechanisms of these peptides are more nuanced than "producing more hormones." We'll examine each compound's actual mechanism below. JRE Episode #1683 — Andrew Huberman In his conversation with Stanford neuroscientist Andrew Huberman, BPC-157 came up in the context of tissue healing research. Huberman provided scientific context while Rogan shared personal experience with elbow recovery. Huberman, known for his detailed scientific explanations, discussed the published research on BPC-157's mechanisms rather than making health claims. JRE Episode #2421 — Derek (More Plates More Dates) In December 2025, Rogan had a lengthy conversation with fitness educator Derek, covering various compounds including peptides. This episode included broader discussion of TRT (testosterone replacement therapy), newer GLP-1 research compounds like retatrutide, and mitochondrial peptides like MOTS-c — topics Derek's More Plates More Dates channel frequently breaks down. Derek's background as a fitness content creator who reads primary literature added depth to the peptide discussion. Listeners searching for the Joe Rogan retatrutide podcast clip are usually referring to this December 2025 conversation. BPC-157: The Research BPC-157 is the peptide most frequently mentioned on Rogan's podcast. Here's what the science actually says. Molecular Identity Full Name Body Protection Compound 157 Structure Pentadecapeptide (15 amino acids) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1419 g/mol Origin Synthetic fragment derived from human gastric juice protein Mechanism of Action Published research identifies several pathways through which BPC-157 may affect tissue: Angiogenesis promotion: Studies show BPC-157 promotes blood vessel formation in animal models (Seiwerth et al., 2018) Nitric oxide system modulation: Interactions with NO pathways have been documented Growth factor activity: Research indicates effects on VEGF and EGF pathways FAK-paxillin pathway: Cell migration studies show activation of focal adhesion kinase Published Research Study Focus Model Publication Seiwerth et al. (2018) Tissue healing mechanisms Animal Current Pharmaceutical Design Gwyer et al. (2019) Tendon repair Systematic review British Journal of Sports Medicine Bauer & Kamysz (2025) Comprehensive review Literature analysis MDPI Pharmaceuticals Important context: The majority of BPC-157 research has been conducted in animal models. Published human clinical trials remain limited. This doesn't mean the compound "doesn't work"—it means the evidence base is predominantly preclinical. TB-500: Thymosin Beta-4 Derivative TB-500 is often discussed alongside BPC-157 in recovery contexts. Here's the published science. For a complete regulatory breakdown, see our TB-500 FDA Approval Status 2026 guide. Molecular Identity Full Name Thymosin Beta-4 fragment (TB-500) Structure Synthetic 43-amino-acid peptide Origin Derived from naturally occurring Thymosin Beta-4 Function Actin-sequestering protein Mechanism of Action TB-500 research has focused on: Actin upregulation: Thymosin Beta-4 is a key regulator of actin polymerization, affecting cell structure and motility Cell migration: Studies show TB-500 promotes cell migration to injury sites in tissue models Wound healing: Research demonstrates involvement in wound healing cascades Angiogenesis: Blood vessel formation has been observed in preclinical models Published Research Study Focus Publication Xing et al. (2021) Thymosin β4 function review Frontiers in Endocrinology Sosne & Kleinman (2015) Tissue repair mechanisms IOVS/Arvo Journals Goldstein et al. (2012) Thymosin β4 mechanisms Expert Opinion on Biological Therapy The BPC-157 + TB-500 Research Stack The so-called Joe Rogan peptide stack — the phrase listeners use when piecing together the peptides Rogan uses across episodes — is essentially BPC-157 plus TB-500. Rogan and his guests have discussed using these multiple peptides in combination. In research contexts, BPC-157 and TB-500 are often studied together because they operate through different but potentially complementary pathways. Rationale for Combination Research Different primary mechanisms: BPC-157 affects growth factor and NO pathways; TB-500 works through actin regulation Overlapping tissue targets: Both have been studied in connective tissue and wound healing models Theoretical synergy: Researchers hypothesize complementary effects, though combination studies are limited The combination is popular in research protocols, though published head-to-head or combination studies remain sparse. For a detailed comparison of these two tissue repair peptides, see our BPC-157 vs TB-500 research guide . For reconstitution math on a combined vial, use the BPC-157 TB-500 blend dosage calculator . Thymosin Alpha-1: Immune Research Rogan mentioned Thymosin on his Flagrant appearance. Thymosin Alpha-1 is the research-relevant form of this peptide. Molecular Identity Structure 28-amino-acid peptide Origin Thymic peptide Research Focus Immune modulation Published Research Thymosin Alpha-1 research has focused on immune system interactions: T-cell activation: Studies show effects on T-lymphocyte maturation Dendritic cell function: Research demonstrates modulation of antigen-presenting cells Clinical use abroad: Approved in some countries (Italy, China) for hepatitis and immune-related conditions Unlike BPC-157 and TB-500, Thymosin Alpha-1 has some approved clinical applications outside the United States, providing a deeper evidence base. Ipamorelin: Growth Hormone Secretagogue Ipamorelin was also mentioned in Rogan's Flagrant appearance. It belongs to a different class than the tissue-focused peptides above. Molecular Identity Class Growth Hormone Releasing Peptide (GHRP) Mechanism Stimulates pituitary gland GH release Distinguishing Feature Selective GH release without affecting cortisol or prolactin Research Context Ipamorelin research has examined: GH secretion patterns: Studies show pulsatile GH release mimicking natural patterns Selectivity: Unlike earlier GHRPs, Ipamorelin shows minimal effect on cortisol and prolactin Recovery research: Some studies have examined applications in tissue repair models Ipamorelin is not FDA-approved and remains a research compound in the United States. For a complete comparison of growth hormone peptides, see our CJC-1295 vs Ipamorelin research guide . Regulatory Status Summary For researchers, understanding the regulatory landscape is essential: Compound FDA Status WADA Status Notes BPC-157 Not approved Not currently listed Research use only; was briefly on WADA watch list TB-500 Not approved Prohibited Research use only Thymosin Alpha-1 Not approved in US Permitted Approved in some countries (Italy, China) Ipamorelin Not approved Prohibited Research use only Key point: None of these compounds are FDA-approved for human therapeutic use in the United States. They are sold for research purposes only. The Difference Between Podcast Discussion and Medical Advice Joe Rogan is an entertainer and podcaster, not a medical professional. His discussions about peptides reflect personal experiences and conversations with guests—not clinical recommendations. When evaluating any information from podcasts: Check the source: Is the speaker citing published research or personal anecdote? Verify claims: Look up the studies mentioned—do they exist? What do they actually show? Understand limitations: Animal studies don't always translate to humans Recognize context: Guests may have commercial interests in products they discuss This article attempts to do exactly that: separate what Rogan has said from what the published science supports. Researching These Compounds? For laboratory investigations into any of the peptides discussed on JRE, research-grade compounds are available from our peptide research catalog . All purchases require certification of research-only intent. Quality verification: We recommend sending samples to independent testing labs like Janoshik or Finnrick before use. Vendor COAs are a starting point—independent verification is the standard for serious research. Reconstitution math: Use our free Peptide Calculator to determine concentration, syringe units, and doses per vial for your research protocols. If the vial is a combined BPC-157 and TB-500 blend, use the BPC-157 TB-500 blend dosage calculator so the total draw is split into estimated BPC-157 and TB-500 amounts. Comparing peptides? For detailed research comparisons, see our BPC-157 vs TB-500 guide , our BPC-157 vs Sermorelin comparison , or our CJC-1295 vs Ipamorelin comparison . Peptide safety: New to research peptides? Read our guide on Are Research Peptides Safe? to understand quality factors, testing standards, and what to look for in a vendor. Our guarantee: If independent testing shows anything below specifications, we'll reship or refund. No questions, no hassle. Frequently Asked Questions What peptides does Joe Rogan take? Joe Rogan has specifically mentioned BPC-157, TB-500, Ipamorelin, and Thymosin in his peptide podcast discussions. Newer research compounds like retatrutide and MOTS-c have also come up in Rogan-adjacent episodes featuring guests like Derek (More Plates More Dates). BPC-157 appears most frequently in his recovery discussions. Rogan has not publicly endorsed a specific Joe Rogan peptides brand or named which BPC-157 Joe Rogan would recommend — he discusses the compounds by name without pointing to a particular vendor. What episode does Joe Rogan discuss BPC-157? BPC-157 has come up in multiple episodes, including JRE #1683 with Andrew Huberman and JRE #1580 with Andrew Schulz. The compound is also mentioned in his Flagrant podcast appearance (June 2022, around 2:16:00). Is BPC-157 FDA approved? No. BPC-157 is not FDA approved for any human therapeutic use. It is a research compound sold for laboratory and investigational purposes only. Where can I get the peptides Joe Rogan mentions? Research-grade peptides are available from laboratory suppliers including PeptideStack. All purchases are for research purposes only and are not for human consumption. Are peptides legal to buy? Research peptides are legal to purchase for laboratory and research purposes in most jurisdictions. They are not approved for human consumption and cannot be sold as medications or supplements. What does Joe Rogan say about TB-500? Rogan has discussed TB-500 in the context of recovery research, often alongside BPC-157. He's mentioned athletes using these compounds, though he clarifies these are not medical recommendations. Sources and Further Reading Seiwerth et al. (2018) — "BPC 157 and Standard Angiogenic Growth Factors: Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing" — Current Pharmaceutical Design Gwyer et al. (2019) — "Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing" — Cell and Tissue Research Xing et al. (2021) — "Thymosin β4: A Potential Anti-Aging Factor" — Frontiers in Endocrinology Goldstein et al. (2012) — "Thymosin β4: a multi-functional regenerative peptide" — Expert Opinion on Biological Therapy Bauer & Kamysz (2025) — "BPC 157: A Comprehensive Review" — MDPI Pharmaceuticals Disclaimer: This article documents statements made on public podcast episodes and summarizes published research. This is not medical advice. The compounds discussed are for laboratory research use only and are not intended for human consumption. PeptideStack does not provide medical recommendations. PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, shipping policy, refund policy, privacy policy, terms, and research disclaimer. The site is organized around research peptide education, supplier transparency, product comparison, vendor review content, discount-code tracking, and calculator tools for reconstitution or unit conversion research planning. PeptideStack separates research-use-only peptide information from FDA-approved medication and licensed telehealth pathways. Research peptide pages are informational and are not medical advice, prescription guidance, dosing instructions, treatment recommendations, or instructions for human consumption. Many pages include affiliate disclosures because PeptideStack may earn a commission when visitors click external supplier or telehealth links. That commission does not change the price paid by visitors and does not mean PeptideStack manufactures, sells, distributes, compounds, or ships peptides or medications. Supplier and product pages should be evaluated for third-party testing, batch-specific certificates of analysis, named laboratory verification, transparent pricing, realistic delivery expectations, payment security, refund policies, support quality, and consistent research-use-only labeling. Blog pages connect related guides, comparison articles, FDA approval status explainers, safety context, legality resources, product pages, vendor reviews, and calculator tools so visitors can keep researching without relying on a single supplier claim. Calculator pages are educational tools for laboratory planning and should be cross-checked against professional protocols, institutional requirements, and applicable laws. Legal and disclaimer pages explain the boundaries of PeptideStack content and the responsibility of visitors who evaluate third-party vendors. The rendered interface may add interactive details such as mobile navigation labels, product tabs, share buttons, related article cards, disclosure boxes, call-to-action buttons, vendor selectors, copy-code controls, email-code forms, footer navigation, and status labels. The static HTML fallback includes this context so the same page purpose is understandable before the JavaScript application finishes loading. Visitors should treat PeptideStack as a research and comparison starting point. Final supplier evaluation should include direct review of the external vendor website, current product availability, checkout terms, applicable laws, institutional requirements, and any third-party laboratory documentation available for the exact product or batch being considered. Footer resources repeat important sitewide context: PeptideStack is independent, affiliate-supported, research-focused, and not a pharmacy or manufacturer. Pages may include links to the iOS app, calculators, blog hubs, product hubs, supplier comparisons, support contact, and policy documents. This repeated context is intentionally available in the raw HTML for crawlers that inspect a page before executing the React bundle. Raw HTML also includes page summaries for mobile crawlers using JavaScript rendering, desktop crawlers comparing source to rendered output, accessibility tools, and no-script visitors. The fallback is replaced by the React app in normal browsers but keeps the source document aligned with the visible page topic. This fallback keeps source HTML and rendered HTML closer for crawl diagnostics and SEO audits across crawled pages, routes, reports, and recrawls.